Decentralized clinical trials (DCTs) are studies in which the need for patients to physically
access hospital-based trial sites is reduced or eliminated. The CoViD-19 pandemic has …

The approach to patient engagement (PE) in drug development has changed rapidly due to
many factors, including the complexity of innovative drugs and the need to demonstrate …

Decentralized clinical trials involving the use of digital tools to facilitate remote research are
gaining momentum. Rapid advancements in digital technologies have supported the …

Clinical trials are the essential assessment for safe, reliable, and effective drug
development. Data-related limitations, extensive manual efforts, remote patient monitoring …

Importance The need to maintain clinical trial recruitment during the COVID-19 pandemic
has precipitated the rapid uptake of digital health for the conduct of clinical trials. Different …

Decentralized clinical trials (DCTs) leverage digital technologies to reduce dependency on
study sites and intermediaries. DCT should be balanced with accessibility and data …

Aims Insights into the current practice of direct‐to‐participant (DtP) supply of investigational
medicinal product (IMP) in the context of clinical trials conducted in Europe are needed, as …

In this Review, we explore the transformative potential of decentralized clinical trials (DCTs)
in addressing the limitations of traditional randomized controlled trials (RCTs). We highlight …

Aim Timely recruitment of eligible participants is essential for the success of clinical trials,
with insufficient accrual being the leading cause for premature termination of both oncology …

Introduction Digital health has gained traction in research and development, and clinical
decision support systems. The COVID-19 pandemic accelerated the adoption of …